On the night of the 10th, an expert group of the Ministry of Health, Labor and Welfare approved the use of the new coronavirus drug developed by Pfizer in Japan.


It is expected to be officially approved on the night of the 10th.

Approved is "Pakirovid Pack (generic name" Nirmatrelville / Ritonavir ")" for patients with mild to moderate disease of the new coronavirus, and 2 for the new corona in Japan. It will be a type.

The Japanese government has agreed to supply 2 million people from Pfizer, of which 40,000 are expected to be supplied as soon as they are approved.